The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Ingestible Smart Pills Market Research Report 2024

Global Ingestible Smart Pills Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1419852

No of Pages : 94

Ask Your Query

Synopsis

Ingestible Smart Pills have outperformed the conventional GI monitoring endoscopy with more convenient technology, which is becoming a standard non-invasive diagnosis technique for motility disorders.

The global Ingestible Smart Pills market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Ingestible Smart Pills, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ingestible Smart Pills.

Report Scope

The Ingestible Smart Pills market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ingestible Smart Pills market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ingestible Smart Pills manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • BodyCap-Medical
  • Philips Respironics
  • Given Imaging
  • Olympus
  • Proteus Digital Health
  • CapsoVision
  • Chongqing Jinshan Science and Component
  • Medimetrics
  • IntroMedic
  • Check-Cap
  • Segment by Type
  • Smart Pills
  • Workstation

Segment by Application

  • Hospitals
  • Clinics
  • Research Institutes
  • Home Healthcare

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ingestible Smart Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ingestible Smart Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Ingestible Smart Pills Market Overview
1.1 Product Overview and Scope of Ingestible Smart Pills
1.2 Ingestible Smart Pills Segment by Type
1.2.1 Global Ingestible Smart Pills Market Value Comparison by Type (2024-2030)
1.2.2 Smart Pills
1.2.3 Workstation
1.3 Ingestible Smart Pills Segment by Application
1.3.1 Global Ingestible Smart Pills Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.3.5 Home Healthcare
1.4 Global Ingestible Smart Pills Market Size Estimates and Forecasts
1.4.1 Global Ingestible Smart Pills Revenue 2019-2030
1.4.2 Global Ingestible Smart Pills Sales 2019-2030
1.4.3 Global Ingestible Smart Pills Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ingestible Smart Pills Market Competition by Manufacturers
2.1 Global Ingestible Smart Pills Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ingestible Smart Pills Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ingestible Smart Pills Average Price by Manufacturers (2019-2024)
2.4 Global Ingestible Smart Pills Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ingestible Smart Pills, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ingestible Smart Pills, Product Type & Application
2.7 Ingestible Smart Pills Market Competitive Situation and Trends
2.7.1 Ingestible Smart Pills Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ingestible Smart Pills Players Market Share by Revenue
2.7.3 Global Ingestible Smart Pills Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ingestible Smart Pills Retrospective Market Scenario by Region
3.1 Global Ingestible Smart Pills Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ingestible Smart Pills Global Ingestible Smart Pills Sales by Region: 2019-2030
3.2.1 Global Ingestible Smart Pills Sales by Region: 2019-2024
3.2.2 Global Ingestible Smart Pills Sales by Region: 2025-2030
3.3 Global Ingestible Smart Pills Global Ingestible Smart Pills Revenue by Region: 2019-2030
3.3.1 Global Ingestible Smart Pills Revenue by Region: 2019-2024
3.3.2 Global Ingestible Smart Pills Revenue by Region: 2025-2030
3.4 North America Ingestible Smart Pills Market Facts & Figures by Country
3.4.1 North America Ingestible Smart Pills Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ingestible Smart Pills Sales by Country (2019-2030)
3.4.3 North America Ingestible Smart Pills Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ingestible Smart Pills Market Facts & Figures by Country
3.5.1 Europe Ingestible Smart Pills Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ingestible Smart Pills Sales by Country (2019-2030)
3.5.3 Europe Ingestible Smart Pills Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ingestible Smart Pills Market Facts & Figures by Country
3.6.1 Asia Pacific Ingestible Smart Pills Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ingestible Smart Pills Sales by Country (2019-2030)
3.6.3 Asia Pacific Ingestible Smart Pills Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ingestible Smart Pills Market Facts & Figures by Country
3.7.1 Latin America Ingestible Smart Pills Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ingestible Smart Pills Sales by Country (2019-2030)
3.7.3 Latin America Ingestible Smart Pills Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ingestible Smart Pills Market Facts & Figures by Country
3.8.1 Middle East and Africa Ingestible Smart Pills Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ingestible Smart Pills Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ingestible Smart Pills Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Ingestible Smart Pills Sales by Type (2019-2030)
4.1.1 Global Ingestible Smart Pills Sales by Type (2019-2024)
4.1.2 Global Ingestible Smart Pills Sales by Type (2025-2030)
4.1.3 Global Ingestible Smart Pills Sales Market Share by Type (2019-2030)
4.2 Global Ingestible Smart Pills Revenue by Type (2019-2030)
4.2.1 Global Ingestible Smart Pills Revenue by Type (2019-2024)
4.2.2 Global Ingestible Smart Pills Revenue by Type (2025-2030)
4.2.3 Global Ingestible Smart Pills Revenue Market Share by Type (2019-2030)
4.3 Global Ingestible Smart Pills Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ingestible Smart Pills Sales by Application (2019-2030)
5.1.1 Global Ingestible Smart Pills Sales by Application (2019-2024)
5.1.2 Global Ingestible Smart Pills Sales by Application (2025-2030)
5.1.3 Global Ingestible Smart Pills Sales Market Share by Application (2019-2030)
5.2 Global Ingestible Smart Pills Revenue by Application (2019-2030)
5.2.1 Global Ingestible Smart Pills Revenue by Application (2019-2024)
5.2.2 Global Ingestible Smart Pills Revenue by Application (2025-2030)
5.2.3 Global Ingestible Smart Pills Revenue Market Share by Application (2019-2030)
5.3 Global Ingestible Smart Pills Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BodyCap-Medical
6.1.1 BodyCap-Medical Corporation Information
6.1.2 BodyCap-Medical Description and Business Overview
6.1.3 BodyCap-Medical Ingestible Smart Pills Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BodyCap-Medical Ingestible Smart Pills Product Portfolio
6.1.5 BodyCap-Medical Recent Developments/Updates
6.2 Philips Respironics
6.2.1 Philips Respironics Corporation Information
6.2.2 Philips Respironics Description and Business Overview
6.2.3 Philips Respironics Ingestible Smart Pills Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Philips Respironics Ingestible Smart Pills Product Portfolio
6.2.5 Philips Respironics Recent Developments/Updates
6.3 Given Imaging
6.3.1 Given Imaging Corporation Information
6.3.2 Given Imaging Description and Business Overview
6.3.3 Given Imaging Ingestible Smart Pills Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Given Imaging Ingestible Smart Pills Product Portfolio
6.3.5 Given Imaging Recent Developments/Updates
6.4 Olympus
6.4.1 Olympus Corporation Information
6.4.2 Olympus Description and Business Overview
6.4.3 Olympus Ingestible Smart Pills Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Olympus Ingestible Smart Pills Product Portfolio
6.4.5 Olympus Recent Developments/Updates
6.5 Proteus Digital Health
6.5.1 Proteus Digital Health Corporation Information
6.5.2 Proteus Digital Health Description and Business Overview
6.5.3 Proteus Digital Health Ingestible Smart Pills Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Proteus Digital Health Ingestible Smart Pills Product Portfolio
6.5.5 Proteus Digital Health Recent Developments/Updates
6.6 CapsoVision
6.6.1 CapsoVision Corporation Information
6.6.2 CapsoVision Description and Business Overview
6.6.3 CapsoVision Ingestible Smart Pills Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CapsoVision Ingestible Smart Pills Product Portfolio
6.6.5 CapsoVision Recent Developments/Updates
6.7 Chongqing Jinshan Science and Component
6.6.1 Chongqing Jinshan Science and Component Corporation Information
6.6.2 Chongqing Jinshan Science and Component Description and Business Overview
6.6.3 Chongqing Jinshan Science and Component Ingestible Smart Pills Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chongqing Jinshan Science and Component Ingestible Smart Pills Product Portfolio
6.7.5 Chongqing Jinshan Science and Component Recent Developments/Updates
6.8 Medimetrics
6.8.1 Medimetrics Corporation Information
6.8.2 Medimetrics Description and Business Overview
6.8.3 Medimetrics Ingestible Smart Pills Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medimetrics Ingestible Smart Pills Product Portfolio
6.8.5 Medimetrics Recent Developments/Updates
6.9 IntroMedic
6.9.1 IntroMedic Corporation Information
6.9.2 IntroMedic Description and Business Overview
6.9.3 IntroMedic Ingestible Smart Pills Sales, Revenue and Gross Margin (2019-2024)
6.9.4 IntroMedic Ingestible Smart Pills Product Portfolio
6.9.5 IntroMedic Recent Developments/Updates
6.10 Check-Cap
6.10.1 Check-Cap Corporation Information
6.10.2 Check-Cap Description and Business Overview
6.10.3 Check-Cap Ingestible Smart Pills Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Check-Cap Ingestible Smart Pills Product Portfolio
6.10.5 Check-Cap Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ingestible Smart Pills Industry Chain Analysis
7.2 Ingestible Smart Pills Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ingestible Smart Pills Production Mode & Process
7.4 Ingestible Smart Pills Sales and Marketing
7.4.1 Ingestible Smart Pills Sales Channels
7.4.2 Ingestible Smart Pills Distributors
7.5 Ingestible Smart Pills Customers
8 Ingestible Smart Pills Market Dynamics
8.1 Ingestible Smart Pills Industry Trends
8.2 Ingestible Smart Pills Market Drivers
8.3 Ingestible Smart Pills Market Challenges
8.4 Ingestible Smart Pills Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock